Skip to main content
Earnings Labs
Cingulate Inc. logo

Cingulate Inc. (CING)

NASDAQ·Healthcare·Biotechnology

$5.30

+11.81%

Mkt Cap $29.49M

Analyst Ratings

Buy

4

Hold

0

Sell

0

Price Target (2 analysts)

$10.00

Range $10.00$10.00

Implied Upside

+88.7%

Consensus $10.00 vs current $5.30